Results 31 to 40 of about 4,350 (187)

A case of paraneoplastic subacute cutaneous lupus erythematosus in a patient with metastatic melanoma [PDF]

JAAD Case Reports, 2021
Jonathan D. D'Gama, PhD, David A. Hashemi, MD, MBA, Flavia Fedeles, MD   +2 more
doaj   +2 more sources

Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects

Anais Brasileiros de Dermatologia, 2023
Cutaneous lupus erythematosus is an autoimmune disease of varied clinical expression, which may present as an exclusively cutaneous disease or be one of the multiple manifestations of systemic lupus erythematosus.
Everton Carlos Siviero do Vale, Lucas Campos Garcia   +1 more
doaj   +1 more source

Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE

Lupus Science and Medicine, 2023
Objective To assess the efficacy of anifrolumab, a type-1 interferon receptor subunit-1 monoclonal antibody, in treating refractory cutaneous lupus erythematosus (CLE) and lupus non-specific mucocutaneous manifestations in patients with systemic lupus ...
Jun Kang, Aaron Bao
doaj   +1 more source

Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects [PDF]

Anais Brasileiros de Dermatologia, 2014
Systemic Lupus Erythematosus is a chronic inflammatory disease with multifactorial etiology. Although clinical manifestations are varied, the skin is an important target-organ, which contributes to the inclusion of skin lesions in 4 out of the 17 new ...
Jucelio Pereira Moura Filho, Raiza Luna Peixoto, Livia Gomes Martins, Sillas Duarte de Melo, Ligiana Leite de Carvalho, Ana Karine F. da Trindade C. Pereira, Eutilia Andrade Medeiros Freire   +6 more
doaj   +1 more source

Ocular discoid lupus erythematosus: More than what meets the eye

Indian Dermatology Online Journal, 2023
Lupus erythematosus is a spectrum that includes auto-immune disorders such as systemic lupus erythematosus (SLE), subacute cutaneous lupus erythematosus (SCLE), and chronic cutaneous lupus erythematosus (CCLE).
Sumiti Pareek, Alpana Mohta, Rajesh Dutt Mehta, Vijeta Prasad   +3 more
doaj   +1 more source

Panoramic view of clinical features of lupus erythematosus: a cross-sectional multicentre study from China

Lupus Science and Medicine, 2023
Objective Lupus erythematosus (LE) is a complicated disease with highly heterogeneous clinical manifestations. Previous studies have rarely included all subgroups of patients with lupus and have overlooked the importance of the cutaneous manifestations ...
Qing Zhang, Haijing Wu, Hai Long, Ming Zhao, Qianjin Lu, Yu Liu, Shuangyan Luo, Yixin Tan, Fen Li, Guanghui Ling, Jieyue Liao, Heng Yin, Peng Zhang, Xin Huang, Siqi Fu, Shuaihantian Luo, Ruifang Wu, Hui Jin, Shihang Zhou, Yangyiyi Yu   +19 more
doaj   +1 more source

Omeprazole-Induced Subacute Cutaneous Lupus Erythematosus. [PDF]

JAMA Dermatol, 2020
Hall EL, Peravali R, Patel TS.
europepmc   +4 more sources

B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity

Frontiers in Immunology, 2021
Cutaneous lupus erythematosus (CLE) is a chronic inflammatory skin disease characterized by a diverse cadre of clinical presentations. CLE commonly occurs in patients with systemic lupus erythematosus (SLE), and CLE can also develop in the absence of ...
Lisa Abernathy-Close, Stephanie Lazar, Jasmine Stannard, Jasmine Stannard, Lam C. Tsoi, Lam C. Tsoi, Lam C. Tsoi, Sean Eddy, Syed M. Rizvi, Christine M. Yee, Emily M. Myers, Rajaie Namas, Lori Lowe, Lori Lowe, Tamra J. Reed, Fei Wen, Johann E. Gudjonsson, J. Michelle Kahlenberg, Celine C. Berthier   +18 more
doaj   +1 more source

Secukinumab‐induced subacute cutaneous lupus erythematosus

Dermatologic Therapy, 2020
N ...
Conforti C., Retrosi C., Giuffrida R., Vezzoni R., Currado D., Navarini L., Farinazzo E., Dell'Aquila C., Nan K., Di Meo N., Zalaudek I.   +10 more
openaire   +3 more sources

Nivolumab-Induced de novo Discoid Lupus Erythematosus

Case Reports in Dermatology, 2022
An increasing number of checkpoint inhibitor-induced subacute cutaneous lupus erythematosus events have been reported. We present the first case of nivolumab-induced discoid lupus erythematosus in a patient with hepatocellular carcinoma.
Jaya Manjunath, Mark Mochel, Fnu Nutan
doaj   +1 more source